{"id":2688,"date":"2014-06-04T22:50:00","date_gmt":"2014-06-04T22:50:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=2688"},"modified":"2025-01-16T15:52:12","modified_gmt":"2025-01-16T15:52:12","slug":"current-and-future-health-and-economic-impact-of-hepatitis-c-in-belgium","status":"publish","type":"post","link":"https:\/\/cdafound.org\/fr\/current-and-future-health-and-economic-impact-of-hepatitis-c-in-belgium\/","title":{"rendered":"Impact sanitaire et \u00e9conomique actuel et futur de l'h\u00e9patite C en Belgique"},"content":{"rendered":"

R\u00e9sum\u00e9<\/h2>\n\n\n\n

Contexte et objectifs de l'\u00e9tude<\/h3>\n\n\n\n

L'infection chronique par le virus de l'h\u00e9patite C (VHC) est un grave probl\u00e8me de sant\u00e9 mondial affectant 150 millions de personnes dans le monde. Bien que les taux d'infection diminuent, une population vieillissante avec une progression de la maladie devrait entra\u00eener une augmentation du fardeau de la maladie \u00e0 un stade avanc\u00e9 avec des co\u00fbts associ\u00e9s \u00e9lev\u00e9s. Cette analyse d\u00e9crit l'impact \u00e9conomique actuel et futur projet\u00e9 des s\u00e9quelles du VHC en Belgique.<\/p>\n\n\n\n

M\u00e9thodes<\/h3>\n\n\n\n

Un mod\u00e8le pr\u00e9c\u00e9demment d\u00e9crit et valid\u00e9 a \u00e9t\u00e9 peupl\u00e9 d'intrants belges et calibr\u00e9 pour projeter la charge sanitaire et \u00e9conomique actuelle et future du VHC. Des analyses de Monte Carlo et de sensibilit\u00e9 ont \u00e9t\u00e9 effectu\u00e9es pour quantifier l'incertitude. Toutes les estimations excluent le co\u00fbt de la th\u00e9rapie antivirale.<\/p>\n\n\n\n

R\u00e9sultats<\/h3>\n\n\n\n

Les co\u00fbts associ\u00e9s au VHC devraient culminer en 2026 \u00e0 126 millions d'euros (30 millions d'euros \u00e0 257 millions d'euros), tandis que les co\u00fbts de la cirrhose d\u00e9compens\u00e9e et du carcinome h\u00e9patocellulaire devraient augmenter jusqu'en 2031 et 2034. Le co\u00fbt cumul\u00e9 projet\u00e9 2014-2030 du VHC dans les conditions actuelles \u00e9tait de 1 850 millions d'euros. . Les sc\u00e9narios visant \u00e0 r\u00e9duire le fardeau du VHC pourraient entra\u00eener des \u00e9conomies cumulatives de 70 \u00e0 400 millions d'euros. Le d\u00e9but du traitement (1000 patients) en 2015 pourrait entra\u00eener des \u00e9conomies de co\u00fbts de 150 millions d'euros. Le co\u00fbt \u00e0 vie du VHC augmente avec l'esp\u00e9rance de vie, les co\u00fbts futurs les plus \u00e9lev\u00e9s \u00e9tant projet\u00e9s chez les jeunes femmes atteintes de la maladie \u00e0 un stade pr\u00e9coce.<\/p>\n\n\n\n

Conclusions<\/h3>\n\n\n\n

Le fardeau \u00e9conomique du VHC et de la maladie \u00e0 un stade avanc\u00e9 devrait encore augmenter. Des r\u00e9ductions de co\u00fbts sont possibles gr\u00e2ce \u00e0 des interventions opportunes visant \u00e0 minimiser le fardeau sanitaire des maladies \u00e0 un stade avanc\u00e9.<\/p>\n\n\n\n

Des pays:<\/strong> Belgique<\/p>\n\n

\n
Lire le rapport complet<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

Summary Background and Study Aims Chronic hepatitis C virus (HCV) infection is a serious global health problem affecting 150 million individuals worldwide. Although infection rates are decreasing, an aging population with progressing disease is expected to result in increased burden of advanced stage disease with high associated costs. This analysis describes the current and projected […]<\/p>\n","protected":false},"author":24,"featured_media":3493,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[32,10],"publication-author":[2244,1134,2095,494,1136,895,1132,1135],"class_list":["post-2688","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-economic-impact","tag-hcv","publication-author-hindman-sj","publication-author-laleman-w","publication-author-moreno-c","publication-author-razavi-h","publication-author-starkel-p","publication-author-van-damme-p","publication-author-van-vlierberghe-h","publication-author-vandijck-d"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=2688"}],"version-history":[{"count":7,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2688\/revisions"}],"predecessor-version":[{"id":7631,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/2688\/revisions\/7631"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media\/3493"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=2688"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/categories?post=2688"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/tags?post=2688"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/publication-author?post=2688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}